Perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate is a bioactive entity that represents a compelling biomaterial in combating multifarious ailments. This compound is widely used in the field of drug development for anti-cancer, anti-inflammatory and immunomodulatory mechanisms.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate is a highly specialized ADC linker designed for the construction of advanced antibody-drug conjugates (ADCs) and targeted bioconjugation applications. As an efficient ADC linker, it enables precise conjugation between monoclonal antibodies and diverse ADC cytotoxins, facilitating controlled delivery of payloads to tumor cells. Its chemical structure features a perfluorophenyl ester for reactive conjugation and a phthalimide-protected tetraethylene glycol spacer, providing both aqueous solubility and flexibility in linker design. In ADC linker design, this compound allows modular bioconjugation strategies that maintain antibody functionality while supporting controlled intracellular release of ADC payloads in the tumor microenvironment.
In the context of ADC payload development, this linker shows compatibility with a broad range of cytotoxic agents, including microtubule inhibitors, DNA-targeting drugs, and other potent ADC payloads. The perfluorophenyl ester enables efficient and site-specific reaction with primary amine groups on antibodies, facilitating reproducible linker attachment and homogeneous ADC construction. Its tetraethylene glycol spacer provides optimal flexibility and reduces steric hindrance, supporting stable conjugation and improving pharmacokinetic properties. By using this ADC linker, researchers can achieve precise control over payload attachment, release kinetics, and antibody integrity, enhancing the overall performance of targeted therapies.
From an application perspective, this linker is widely utilized in oncology-focused ADC research, bioconjugation studies, and targeted drug delivery systems. Its chemical versatility allows the design of cleavable or non-cleavable ADC linker strategies tailored to therapeutic objectives. The linker’s predictable reactivity and solubility enable efficient conjugation under mild conditions, maintaining antibody functionality and ensuring efficient intracellular payload release. The combination of site-specific reactivity, aqueous compatibility, and structural flexibility makes this linker a valuable tool for constructing next-generation antibody-drug conjugates with high tumor specificity and optimized therapeutic outcomes.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00487 | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | 160580-70-1 | |
BADC-00426 | Perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate | 886209-60-5 | |
BADC-00468 | perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | ||
BADC-00481 | perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate | ||
BADC-00385 | perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate | ||
BADC-00387 | perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate | ||
BADC-00400 | perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate | ||
BADC-00402 | perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate | ||
BADC-00420 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | ||
BADC-00422 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate |
What is perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate and its function in ADC synthesis?
This bifunctional linker contains a perfluorophenyl ester and a phthalimide-protected amino group. It enables selective conjugation to amines on antibodies and provides a PEG-based spacer to improve solubility and flexibility of ADCs.
15/9/2021
Could you explain how this linker enhances ADC properties?
The PEG spacer reduces steric hindrance and aggregation, improving solubility and pharmacokinetics. The perfluorophenyl ester provides efficient amine coupling, allowing controlled payload attachment while preserving antibody function.
8/7/2019
We would like to know which payloads are compatible with this linker.
It can conjugate amine-containing cytotoxins, peptides, and fluorophores. The PEG-based structure maintains ADC solubility and facilitates site-specific payload attachment for improved therapeutic performance.
12/2/2020
Could you please advise the recommended conjugation conditions?
Conjugation is typically performed in slightly basic organic-aqueous solvents (pH 7–8.5) at mild temperatures to ensure perfluorophenyl ester reactivity while maintaining antibody and payload stability.
20/9/2021
Good afternoon! What are the recommended handling and storage procedures for perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate?
This product should be stored in a cool, dry environment, protected from light and moisture. Handling requires gloves and protective equipment to avoid hydrolysis or degradation. Inert gas or vacuum-sealed storage is recommended for long-term stability. Supporting documentation provides detailed guidelines.
5/7/2022
— Dr. Oliver Brown, Senior Scientist (UK)
This PFP ester showed excellent stability and reactivity for PEG-based linker conjugations.
12/2/2020
— Ms. Clara Weber, Biochemist (Germany)
High purity facilitated smooth integration into complex multi-step syntheses.
5/7/2022
— Dr. Ethan Parker, Medicinal Chemist (USA)
The reagent performed consistently, yielding reproducible results in all trials.
20/9/2021
— Dr. Sophie Moreau, Senior Scientist (France)
We observed minimal side reactions and high conjugation efficiency.
15/9/2021
— Dr. Liam Fischer, Chemist (UK)
The extended PEG chain allowed improved solubility and flexibility for our ADC constructs.
— Ms. Clara Müller, Medicinal Chemist (Germany)
This perfluorophenyl ester showed high purity and consistent performance in our conjugation experiments. BOC Sciences provided detailed handling instructions.
8/7/2019
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.